Harrod A, Lai CF, Goldsbrough I, Simmons GM, et al. Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer. Oncogene 2022 Oct 5. pii: 10.1038/s41388-022-02483.
PMID: 36198774